An observational study in Postoperative Care, sponsored by Kanuni Sultan Suleyman Training and Research Hospital. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-02.
Sponsored by Kanuni Sultan Suleyman Training and Research Hospital · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
The optimal duration and intensity of intensive care monitoring after surgery is largely determined by clinical experience rather than by objective, time-based evidence. This prospective observational cohort study aims to determine how frequently clinically significant complications occur in adult patients admitted to a postoperative intensive care unit (ICU), and - more specifically - when they occur during the first 24 hours after ICU admission. Patients will be followed under standard clinical care, with no additional intervention.
The time of ICU admission is defined as hour 0. Complications are recorded with their exact time of first onset, and cumulative incidence is calculated for the predefined windows 0-2, 2-6, 6-8, 8-12 and 12-24 hours. The study will assess whether complications cluster in the early postoperative period (first 6-8 hours) and what proportion of the total 24-hour complication burden this early window represents. A separate analysis will determine how often patients who remain complication-free during the first 6 hours subsequently develop a new, clinically significant complication. The findings are intended to inform evidence-based decisions about the required duration of close postoperative ICU monitoring
Design and setting This is a single-centre, prospective, observational cohort study conducted in the postoperative (surgical) intensive care unit of the Department of Anesthesiology and Reanimation of a tertiary training and research hospital. Population Consecutive adult patients (>=18 years) admitted to the ICU for postoperative monitoring after elective or emergency surgery will be enrolled. No study-specific intervention is performed; all patients receive standard clinical care. All data are extracted from routinely collected clinical records: patient charts, anaesthesia records, ICU observation forms, hourly nursing charts, monitor recordings and laboratory results. Time definition The moment of ICU admission is defined as hour 0. All patients are followed from this reference point. Systematic assessments are performed at 0-2, 2-6, 6-8, 8-12 and 12-24 hours. In addition, hourly nursing and monitor records are used to determine the timing of each complication as precisely as possible (hour and, where available, minute level). For every complication, the time of first onset is recorded separately. Data collected Demographic and preoperative data (age, sex, height, weight, body mass index, ASA physical status, comorbidities, preoperative laboratory values, chronic medication); intraoperative data (surgical specialty and procedure type, elective vs emergency status, duration of surgery, anaesthetic technique, intraoperative hypotension or arrhythmia, fluid and blood product administration, vasopressor/inotrope requirement, extubation status); and postoperative ICU monitoring parameters recorded within each time window (heart rate, mean arterial pressure, vasopressor/inotrope use and dose changes, SpO2, respiratory rate, mode of oxygen therapy, mechanical ventilation status, reintubation, hourly urine output, serum creatinine, level of consciousness, sedation/agitation level, delirium assessment where applicable, arterial blood gas, haemoglobin/haematocrit, troponin and lactate where available). Complication assessment Complications are assessed against predefined objective criteria. Only events that are clinically significant and/or require intervention are recorded as complications. For each complication, the time of first onset, the diagnostic criterion applied, the requirement for clinical intervention and whether the event was recurrent are recorded separately.
Where a patient develops more than one complication, each is recorded as a separate event and the time of the first complication is additionally analysed. Predefined complication categories are: acute kidney injury, cardiac arrhythmia, respiratory complications, haemodynamic instability, neurological complications, bleeding and transfusion requirement, and infectious complications. Complication severity is graded using the Clavien-Dindo classification. Complication types, timing of onset and early-window complication rates are analysed separately for each group. 7. Study Design Study Type Observational Observational Study Model Cohort be calculated for the 0-6, 0-8, 8-12 and 12-24 hour windows. Early complication development (first 6-8 hours) will be defined as a binary variable and its capacity to represent the total complication burden will be analysed. Independent risk factors will be identified by logistic regression, with Cox regression where time-dependent effects require assessment. Results will be reported with odds ratios and 95% confidence intervals. Ethics The study will be conducted in accordance with the Declaration of Helsinki and the principles of Good Clinical Practice. All data will be anonymised. The study involves no additional intervention and poses no risk to participants.
Kanuni Sultan Suleyman Training and Research Hospital is the lead sponsor of 225 studies on the registry; 35 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Adult patients admitted to the postoperative (surgical) intensive care unit of a tertiary training and research hospital for postoperative monitoring following elective or emergency surgery.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Adult patients admitted to the postoperative (surgical) intensive care unit for routine postoperative monitoring following elective or emergency surgery. No study intervention is applied; patients are observed under standard clinical care for the first 24 hours after ICU admission. Prespecified subgroup analyses are performed by surgical specialty.
Cumulative incidence of clinically significant postoperative complications by time
Number and percentage of patients developing at least one predefined, clinically significant postoperative complication within each time window after ICU admission (0-2, 2-6, 6-8, 8-12 and 12-24 hours). Complication categories are acute kidney injury,arrhythmia, respiratory complications, haemodynamic instability, neurological complications, bleeding requiring transfusion, and infectious complications. Only events meeting predefined objective diagnostic criteria and judged clinically significant and/or requiring intervention are counted.
Time frame: First 24 hours after ICU admission
Time to first complication
Time in hours from ICU admission to onset of the first clinically significant complication
Time frame: 24 hour
New complications after an event-free first 6 hours
Proportion of patients free of any clinically significant complication during the first 6 hours who subsequently develop a new clinically significant complication.
Time frame: 6 to 24 hours
Complication severity
Severity of each recorded complication graded by the Clavien-Dindo classification
Time frame: 24 hours
Complication type and timing by surgical specialty
Distribution of complication categories and time of first onset, analysed separately for each surgical specialty subgroup
Time frame: 24 hours
Independent risk factors for complication development
Patient and perioperative variables independently associated with complication development
Time frame: 24 hours
Plan to share: Undecided
No publications or documents are linked to this record.
Start is estimated for Sep 2026; primary completion for Sep 2027, 12 months later.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Kanuni Sultan Suleyman Training and Research Hospital →